why choose us

First received: August 21, 2023

Clinical Trial: The Immunologic Effects of Dupilumab in the Treatment of Dermal Hypersensitivity Reaction

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Dermal Hypersensitivity Reaction

Study Type: INTERVENTIONAL


Official Title: The Immunologic Effects of Dupilumab in the Treatment of Dermal Hypersensitivity Reaction

Brief Summary: This research is studying a drug called dupilumab to learn about its safety and its effect as a treatment for participants with dermal hypersensitivity reaction.This study will help better understand why and how dermal hypersensitivity reaction occurs and how dupilumab might help treat this condition.

Read more